Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammagard Liquid IV vs SC in PID
NCT00546871Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2007
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in primary immunodeficiency disease (PID), sponsored by Takeda. Started Oct 2007; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT00546871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546871.